Treatment for First Cytomegalovirus Infection. Post-Hematoporetic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir
Lisa Hiskey, DO
Mayo Clinic
Treatment for First Cytomegalovirus Infection. Post-Hematoporetic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir
Lisa Hiskey, DO
Mayo Clinic
Critical Appraisal
Jeffrey S. Gerber, MD, PhD - University of Pennsylvania School of Medicine
Yun Li, PhD - University of Pennsylvania, Children's Hospital of Philadelphia
Choosing a Paper for Journal Club
Ravi Jhaveri, MD
Ann & Robert H. Lurie Children's Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine